Welltower Inc (NYSE:WELL) stock rose 1.69% (As on September 23, 11:25:12 AM UTC-4, Source: Google Finance) after UBS initiated coverage of the company with a Buy rating and $195 price target. UBS expects a long tail of positive estimate revisions and AFFO growth that support Welltower’s premium valuation, the firm tells investors in a research note. The firm expects “a long tail of positive estimate revisions and AFFO growth” that support Welltower’s premium valuation, with upside to 2026 and 2027 consensus AFFO of 3% and 5%, respectively. UBS identified four key growth drivers: sustained organic growth from favorable senior housing supply/demand dynamics, greater than expected acquisition volume increasing SHOP (senior housing operating portfolio) exposure to 70% by 2027 from the current 59%, continued Welltower Business System implementation, and the company’s new fund business. The firm projects Welltower’s SHOP will achieve occupancy gains of approximately 880 basis points over the next several years, assuming peak occupancy of 96%, which will power healthy rate growth of 5%-7%. UBS acknowledged that Welltower shares trade at a premium next-twelve-months FFO multiple of 30x compared to its five-year average of 23x, and at a 95% premium to Healthcare REITs versus its five-year average premium of 65%, but expects the company to “grow into its valuation.”
KeyBanc raised its price target on Welltower, Inc. to $200.00 from $150.00 on Tuesday, while maintaining an Overweight rating on the healthcare real estate investment trust. The firm cited Welltower’s strong position to capitalize on multiyear fundamental tailwinds within the senior housing sector. KeyBanc noted that operating momentum remains robust for the company, potentially leading to additional upside to 2025 guidance. This momentum is reflected in Welltower’s strong 32% revenue growth over the last twelve months, with InvestingPro data showing the company maintains a “GREAT” overall financial health score. The analyst report highlighted expectations for stable-to-improving RevPOR (revenue per occupied room) growth in 2026, along with further margin expansion for Welltower’s operations.
KeyBanc also pointed to new investments as drivers of earnings accretion that should sustain Welltower’s above-average NFFO (normalized funds from operations) growth. This growth is supported by the company’s access to attractively priced capital and below-average leverage. The price target increase comes as KeyBanc raised its financial estimates for Welltower while reiterating its Overweight rating on the stock.
In other recent news, Welltower Inc. reported its financial results for the second quarter of 2025, meeting earnings expectations with an earnings per share (EPS) of $0.45. The company exceeded revenue projections, reporting $2.55 billion against an expected $2.45 billion, marking a 4.08% surprise.
Additionally, Welltower filed a prospectus supplement with the Securities and Exchange Commission to register the offer and resale of up to 949,412 shares of its common stock. These shares were issued as part of a recent property acquisition. The registration forms part of Welltower’s automatic shelf registration statement on Form S-3. These developments highlight significant activity within the company as it continues to expand its portfolio.